Literature DB >> 18443631

eIF4E, the mRNA cap-binding protein: from basic discovery to translational research.

Nahum Sonenberg1.   

Abstract

Translational control is an important strategy by which eukaryotic cells regulate gene expression. Translation is the last step in the flow of genetic information, and regulation at this level allows an immediate and rapid response to changes under physiological conditions. Because the processes of mRNA biogenesis, including transcription, splicing, and export to the cytoplasm, are time consuming, the use of pre-existing mRNAs via the control of translation is advantageous in many circumstances. A prime target of translational control is the initiation factor eIF4E, which recognizes the m7GpppN cap structure present at the 5' end of all nuclear transcribed eukaryotic mRNAs. In this article I describe the discovery of eIF4E, its mechanism of action in translation initiation, and its role in the control of cancer and innate immunity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18443631     DOI: 10.1139/O08-034

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  87 in total

Review 1.  Posttranscriptional regulation of cancer traits by HuR.

Authors:  Kotb Abdelmohsen; Myriam Gorospe
Journal:  Wiley Interdiscip Rev RNA       Date:  2010-05-06       Impact factor: 9.957

2.  Mnk earmarks eIF4E for cancer therapy.

Authors:  Nissim Hay
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

3.  Tombusvirus recruitment of host translational machinery via the 3' UTR.

Authors:  Beth L Nicholson; Baodong Wu; Irina Chevtchenko; K Andrew White
Journal:  RNA       Date:  2010-05-27       Impact factor: 4.942

4.  Synthesis, properties, and biological activity of boranophosphate analogs of the mRNA cap: versatile tools for manipulation of therapeutically relevant cap-dependent processes.

Authors:  Joanna Kowalska; Anna Wypijewska del Nogal; Zbigniew M Darzynkiewicz; Janina Buck; Corina Nicola; Andreas N Kuhn; Maciej Lukaszewicz; Joanna Zuberek; Malwina Strenkowska; Marcin Ziemniak; Maciej Maciejczyk; Elzbieta Bojarska; Robert E Rhoads; Edward Darzynkiewicz; Ugur Sahin; Jacek Jemielity
Journal:  Nucleic Acids Res       Date:  2014-08-22       Impact factor: 16.971

5.  Apical Na+-D-glucose cotransporter 1 (SGLT1) activity and protein abundance are expressed along the jejunal crypt-villus axis in the neonatal pig.

Authors:  Chengbo Yang; David M Albin; Zirong Wang; Barbara Stoll; Dale Lackeyram; Kendall C Swanson; Yulong Yin; Kelly A Tappenden; Yoshinori Mine; Rickey Y Yada; Douglas G Burrin; Ming Z Fan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-10-28       Impact factor: 4.052

6.  Neprilysin is identical to skin fibroblast elastase: its role in skin aging and UV responses.

Authors:  Naoko Morisaki; Shigeru Moriwaki; Yoriko Sugiyama-Nakagiri; Keiichi Haketa; Yoshinori Takema; Genji Imokawa
Journal:  J Biol Chem       Date:  2010-09-28       Impact factor: 5.157

Review 7.  RNA granules: post-transcriptional and epigenetic modulators of gene expression.

Authors:  Paul Anderson; Nancy Kedersha
Journal:  Nat Rev Mol Cell Biol       Date:  2009-06       Impact factor: 94.444

Review 8.  From unwinding to clamping - the DEAD box RNA helicase family.

Authors:  Patrick Linder; Eckhard Jankowsky
Journal:  Nat Rev Mol Cell Biol       Date:  2011-07-22       Impact factor: 94.444

9.  RNA-binding motif protein 35A is a novel tumor suppressor for colorectal cancer.

Authors:  Olga V Leontieva; Yuri Ionov
Journal:  Cell Cycle       Date:  2009-02-22       Impact factor: 4.534

10.  Identification of gemin5 as a novel 7-methylguanosine cap-binding protein.

Authors:  Shelton S Bradrick; Matthias Gromeier
Journal:  PLoS One       Date:  2009-09-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.